AAAAAA
Results:
1-11
|
Results: 11
Authors:
Vergnenegre, A
Citation: A. Vergnenegre, Auditing respiratory intensive care units, REV MAL RES, 18(5), 2001, pp. 507-516
Authors:
Melloni, B
Vergnenegre, A
Lagrange, P
Bonnaud, F
Citation: B. Melloni et al., Household radon exposure, REV MAL RES, 17(6), 2000, pp. 1061-1071
Authors:
Robinet, G
Thomas, P
Perol, M
Vergnenegre, A
Lena, H
Taytard, A
Paillotin, D
Bessa, EH
Schuller-Lebeau, MP
Citation: G. Robinet et al., Efficacy of docetaxel in non-small-cell lung cancer patients previously treated with paltinum-containing chemotherapy, REV MAL RES, 17(1), 2000, pp. 83-89
Authors:
Robinet, G
Thomas, P
Perol, M
Vergnenegre, A
Lena, H
Taytard, A
Paillotin, D
Bessa, E
Schuller-Lebeau, MP
Citation: G. Robinet et al., Phase II study of docetaxel in inoperable advanced non small cell lung cancer, B CANCER, 87(3), 2000, pp. 253-258
Authors:
Aboyans, V
Lacroix, P
Waruingi, W
Bertin, F
Pesteil, F
Vergnenegre, A
Laskar, M
Citation: V. Aboyans et al., French translation and validation of the Edinburgh questionnaire for the diagnosis of intermittent limping., ARCH MAL C, 93(10), 2000, pp. 1173-1177
Authors:
Annemans, L
Giaccone, G
Vergnenegre, A
Citation: L. Annemans et al., The cost-effectiveness of paclitaxel (Taxol (R)) plus cisplatin is similarto that of teniposide plus cisplatin in advanced non-small cell lung cancer: a multicountry analysis, ANTI-CANC D, 10(6), 1999, pp. 605-615
Authors:
Vergnenegre, A
Citation: A. Vergnenegre, PMSI and resource allocation - Optimization, REV MAL RES, 16, 1999, pp. S22-S23
Authors:
Vergnenegre, A
Citation: A. Vergnenegre, Health economics - Economic evaluation of lung cancer, REV MAL RES, 16, 1999, pp. S38-S39
Authors:
Vergnenegre, A
Druet-Cabanac, M
Rymer, R
Citation: A. Vergnenegre et al., Interventional radiology and DRGs (diagnosis related groups): Impact on a radiology department, J RADIOLOG, 80(6), 1999, pp. 565-568
Authors:
Vergnenegre, A
Thomas, P
Robinet, G
Pibarot, M
Paillotin, D
Vernejoux, JM
Thiberville, L
Lena, H
Kleisbauer, JP
Gimonet, JF
Citation: A. Vergnenegre et al., High dose ifosfamide for patients with stage IV non small cell lung cancer: phase II trial from the Group francais de pneumo-cancerologie (GFPC), B CANCER, 86(12), 1999, pp. 1017-1021
Authors:
Vergnenegre, A
Grignet, JP
Citation: A. Vergnenegre et Jp. Grignet, Methodology for assessing continuing medical education at the first unitedFrench congress of pneumology., REV MAL RES, 15(6), 1998, pp. 773-779
Risultati:
1-11
|